2013
DOI: 10.5966/sctm.2013-0026
|View full text |Cite
|
Sign up to set email alerts
|

Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model

Abstract: There is a significant clinical need for effective therapies for primary progressive multiple sclerosis, which presents later in life (i.e., older than 50 years) and has symptoms that increase in severity without remission. With autologous mesenchymal stem cell therapy now in the early phases of clinical trials for all forms of multiple sclerosis (MS), it is necessary to determine whether autologous stem cells from older donors have therapeutic effectiveness. In this study, the therapeutic efficacy of human ad… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
73
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 80 publications
(75 citation statements)
references
References 40 publications
1
73
0
Order By: Relevance
“…41 For example, aged MSC cells fail to alleviate autoimmune phenotypes in mouse models, a phenomenon that is likely due to reduced migration ability and reduced expression of anti-inflammatory cytokines. 42,43 Aged MSCs also show reduced ability to repair bone fracture and decreased response to PTH(1-34) treatment. 44 Furthermore, aging makes MSC cells more susceptible to stress-induced senescence.…”
Section: Aging Of Mscsmentioning
confidence: 99%
“…41 For example, aged MSC cells fail to alleviate autoimmune phenotypes in mouse models, a phenomenon that is likely due to reduced migration ability and reduced expression of anti-inflammatory cytokines. 42,43 Aged MSCs also show reduced ability to repair bone fracture and decreased response to PTH(1-34) treatment. 44 Furthermore, aging makes MSC cells more susceptible to stress-induced senescence.…”
Section: Aging Of Mscsmentioning
confidence: 99%
“…Higher expression of HGF in O2 and similar expression value in some groups expressed that there were individual variation between donors but mostly younger donor seems a little higher than older donor. Those various different expression in RNA levels between young and old ASCs were also reported by Scruggs et al (2013). After co-cultured with human ASCs in IVM system, the expression of all genes in cumulus ( Figure 2) were significantly increased and apoptotic ratio also lower than control.…”
Section: Discussionmentioning
confidence: 67%
“…ASCs exhibit stable growth and proliferation kinetics and can differentiate toward osteogenic, chondrogenic, adipogenic, myogenic, or neurogenic lineages in vitro (Scruggs et al 2013;Shimada et al 2006) which has potential as cell feeder in co-culture system. But biologic aging also occurs in stem cells which was shown with secrete less growth factors and other bioactive molecules (Scruggs et al 2013). Those reports showed the important of donor age that should be considered when select ASCs as cell feeder in co-culture system.…”
Section: Introduc Onmentioning
confidence: 99%
“…In mouse ASCs, the level of secreted HGF increases with age despite a decrease in VEGF [26]. In human ASCs, basal levels of HGF in ASCs from donors >60 years of age are similar to levels in young ASCs from donors <35 years of age, although inducible expression of HGF by macrophage-CM is impaired in ASCs from older donors [45]. In human amnion MSCs, the expression levels of HGF do not change after serial passages, although the levels of VEGF and FGF-2 decrease in a passage number-dependent manner [46].…”
Section: Discussionmentioning
confidence: 86%